1. Home
  2. PDS vs SVRA Comparison

PDS vs SVRA Comparison

Compare PDS & SVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Precision Drilling Corporation

PDS

Precision Drilling Corporation

SELL

Current Price

$85.09

Market Cap

1.1B

Sector

N/A

ML Signal

SELL

Logo Savara Inc.

SVRA

Savara Inc.

SELL

Current Price

$4.74

Market Cap

1.1B

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
PDS
SVRA
Founded
1951
2007
Country
Canada
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.1B
IPO Year
1998
2009

Fundamental Metrics

Financial Performance
Metric
PDS
SVRA
Price
$85.09
$4.74
Analyst Decision
Buy
Strong Buy
Analyst Count
10
9
Target Price
★ $100.96
$11.06
AVG Volume (30 Days)
66.5K
★ 2.3M
Earning Date
10-27-2026
11-11-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$11.01
N/A
Revenue Next Year
$4.98
$4,406.08
P/E Ratio
$884.15
★ N/A
Revenue Growth
★ N/A
N/A
52 Week Low
$53.68
$3.50
52 Week High
$103.80
$7.01

Technical Indicators

Market Signals
Indicator
PDS
SVRA
Relative Strength Index (RSI) 50.33 38.36
Support Level $82.18 $4.73
Resistance Level $85.28 $5.53
Average True Range (ATR) 2.57 0.23
MACD 0.26 -0.01
Stochastic Oscillator 59.18 24.22

Price Performance

Historical Comparison
PDS
SVRA

About PDS Precision Drilling Corporation

Precision Drilling Corp is a provider of contract drilling, completion, and production services to oil and natural gas exploration and production companies in Canada, the United States, and certain international locations. The company operates through two industry segments: Contract Drilling Services, which generates maximum revenue and includes drilling rigs, procurement and distribution of oilfield supplies, and the manufacture, sale, and repair of drilling equipment; and Completion and Production Services, which includes service rigs, oilfield equipment rental, and camp services. The company generates the majority of its revenue from the United States.

About SVRA Savara Inc.

Savara Inc is a clinical-stage biopharmaceutical company. It is focused on rare respiratory diseases. It has one segment specialty pharmaceuticals within the respiratory system. The company's main product candidate, molgramostim, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP).

Share on Social Networks: